Fulgent Genetics (FLGT) Accumulated Expenses (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Accumulated Expenses data on file, last reported at $34.9 million in Q1 2026.

• Quarterly Accumulated Expenses rose 603.22% year-over-year to $34.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.9 million (up 603.22% YoY) and the FY2025 annual result came in at $5.2 million, down 78.43% from the prior year.
• Accumulated Expenses climbed to $34.9 million in Q1 2026 per FLGT's latest filing, from $5.2 million in the prior quarter.
• The five-year high for Accumulated Expenses was $34.9 million in Q1 2026, with the low at $3.8 million in Q1 2024.
• Average Accumulated Expenses over 5 years is $18.1 million, with a median of $21.7 million recorded in 2025.
• Year-over-year, Accumulated Expenses tumbled 82.15% in 2024 and soared 603.22% in 2026.
• Fulgent Genetics' Accumulated Expenses stood at $25.0 million in 2022, then tumbled by 77.02% to $5.7 million in 2023, then soared by 322.91% to $24.3 million in 2024, then tumbled by 78.43% to $5.2 million in 2025, then soared by 566.56% to $34.9 million in 2026.
• Business Quant data shows FLGT's Accumulated Expenses at $34.9 million in Q1 2026, $5.2 million in Q4 2025, and $23.0 million in Q3 2025.